Retrospective Study
Copyright ©The Author(s) 2024.
World J Clin Oncol. May 24, 2024; 15(5): 635-643
Published online May 24, 2024. doi: 10.5306/wjco.v15.i5.635
Table 2 Best overall response (patients with measurable lesions)

Group A (N = 42)
Group B (N = 21)
P value
n (%)
95%CI
n (%)
95%CI
Best overall response
    Complete response (CR)0-0--
    Partial response (PR)30 (71.4)-9 (42.9)--
    Stable disease (SD)12 (28.6)-10 (47.6)--
    Progressive disease0 (0)-2 (9.5)--
Overall response rate (CR + PR)30 (71.4)55.4-84.39 (42.9)21.8-66.00.03
Disease control rate (CR + PR + SD)42 (100)91.6-1.0019 (90.5)69.6-98.82.527e-13